Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Rev. Soc. Bras. Med. Trop ; 52: e20180473, 2019. tab
Article Dans Anglais | LILACS | ID: biblio-990445

Résumé

Abstract INTRODUCTION: Candidiasis is the most frequent opportunistic mycosis in humans and can cause mortality, particularly in immunodeficient patients. One major concern is the increasing number of infections caused by drug-resistant Candidas trains, as these cannot be efficiently treated with standard therapeutics. The most common mechanism of fluconazole resistance in Candida is mutation of ERG11, a gene involved in the biosynthesis of ergosterol, a compound essential for cell integrity and membrane function. METHODS: Based on this knowledge, we investigated polymorphisms in the ERG11 gene of 3 Candida species isolated from immunocompromised and immunocompetent patients. In addition, we correlated the genetic data with the fluconazole susceptibility profile of the Candida isolates. RESULTS: A total of 80 Candida albicans, 8 Candida tropicalis and 6 Candida glabrata isolates were obtained from the saliva of diabetic, kidney transplant and immunocompetent patients. Isolates were considered susceptible to fluconazole if the minimum inhibitory concentration was lower than 8 μg/mL. The amino acid mutations F105L, D116E, K119N, S137L, and K128T were observed in C. albicans isolates, and T224C and G263A were found in C. tropicalis isolates. CONCLUSIONS: Despite the high number of polymorphisms observed, the mutations occurred in regions that are not predicted to interfere with ergosterol synthesis, and therefore are not related to fluconazole resistance.


Sujets)
Humains , Mâle , Femelle , Adulte , Sujet âgé , Polymorphisme génétique/effets des médicaments et des substances chimiques , Candida/effets des médicaments et des substances chimiques , Candida/génétique , Fluconazole/pharmacologie , Transplantation rénale , Diabète/microbiologie , Antifongiques/pharmacologie , Valeurs de référence , Salive/microbiologie , Candida/isolement et purification , ADN fongique/génétique , Tests de sensibilité microbienne , Réaction de polymérisation en chaîne , Résistance des champignons aux médicaments/génétique , Immunocompétence , Adulte d'âge moyen , Mutation/effets des médicaments et des substances chimiques
2.
Mem. Inst. Oswaldo Cruz ; 111(7): 417-422, tab, graf
Article Dans Anglais | LILACS | ID: lil-787553

Résumé

Yeasts of the genus Candida have high genetic variability and are the most common opportunistic pathogenic fungi in humans. In this study, we evaluated the genetic diversity among 120 isolates of Candida spp. obtained from diabetic patients, kidney transplant recipients and patients without any immune deficiencies from Paraná state, Brazil. The analysis was performed using the ITS1-5.8S-ITS2 region and a partial sequence of 28S rDNA. In the phylogenetic analysis, we observed a consistent separation of the species C. albicans, C. dubliniensis, C. glabrata, C. tropicalis, C. parapsilosis, C. metapsilosis and C. orthopsilosis, however with low intraspecific variability. In the analysis of the C. albicans species, two clades were formed. Clade A included the largest number of isolates (91.2%) and the majority of isolates from GenBank (71.4%). The phylogenetic analysis showed low intraspecific genetic diversity, and the genetic polymorphisms between C. albicans isolates were similar to genetic divergence found in other studies performed with isolates from Brazil. This low genetic diversity of isolates can be explained by the geographic proximity of the patients evaluated. It was observed that yeast colonisation was highest in renal transplant recipients and diabetic patients and that C. albicans was the species most frequently isolated.


Sujets)
Humains , Mâle , Femelle , Candida/génétique , Candidose invasive/génétique , Diabète/microbiologie , Variation génétique , Transplantation rénale , Brésil/épidémiologie , Candida/classification , Candida/isolement et purification , Candidose invasive/classification , Candidose invasive/épidémiologie , Candidose invasive/microbiologie , Études cas-témoins , Complications du diabète , ADN fongique/analyse , ADN ribosomique/génétique , Tests de sensibilité microbienne
SÉLECTION CITATIONS
Détails de la recherche